Accretion Pharmaceuticals
add_icon

Accretion Pharmaceuticals

88.00
-1.90
(-2.11%)
Market Cap
₹97.82 Cr
PE Ratio
14.71
Volume
20,400.00
Day High - Low
₹90.00 - ₹88.00
52W High-Low
₹102.50 - ₹53.80
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
97.82 Cr
EPS
8.48
PB Ratio
2.22
Book Value
40.52
EBITDA
12.00
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
44.44
Debt to Equity
1.33
Forecast For
Actual
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,737.00
#1 4,16,764.48
40.16
#1 54,729.00
9.71
#1 10,980
2.89
41.99
6,496.50
1,72,461.66
69.16
9,712.00
18.67
2,191
35.10
54.95
3,834.30
1,29,770.14
60.40
11,539.40
6.99
1,911
30.46
64.03
1,496.30
1,20,864.24
22.30
28,409.50
7.12
5,291
3.71
43.36
1,265.80
1,05,645.41
18.66
33,741.20
16.73
5,725
-0.38
50.22
2,107.00
96,238.18
22.21
22,909.50
13.74
3,306
#1 72.75
58.72
917.80
92,352.16
#1 18.57
23,511.00
18.55
4,615
34.60
41.66
2,193.30
90,530.32
51.90
12,744.20
#1 20.90
2,007
-21.05
47.28
1,211.40
70,358.31
20.66
32,345.60
9.43
3,484
3.81
55.09
5,566.00
66,549.88
27.75
13,458.30
3.70
2,216
10.98
44.89
Growth Rate
Revenue Growth
329.10 %
Net Income Growth
353.33 %
Cash Flow Change
149.96 %
ROE
63.50 %
ROCE
238.94 %
EBITDA Margin (Avg.)
4.04 %

Yearly Financial Results

Annual Financials
2024
2025
TTM
Revenue
13
58
0
Expenses
11
46
0
EBITDA
3
12
0
Operating Profit %
20 %
21 %
0 %
Depreciation
0
1
0
Interest
1
1
0
Profit Before Tax
2
10
0
Tax
1
3
0
Net Profit
2
7
0
EPS in ₹
11.08
8.48
0.00

Balance Sheet

Balance Sheet
2024
2025
Total Assets
27
40
Fixed Assets
5
6
Current Assets
22
34
Capital Work in Progress
0
0
Investments
0
0
Other Assets
22
34
Total Liabilities
27
40
Current Liabilities
15
23
Non Current Liabilities
7
1
Total Equity
6
15
Reserve & Surplus
2
7
Share Capital
4
8

Cash Flow

Cash Flow
2024
2025
Net Cash Flow
0
0
Investing Activities
-6
-2
Operating Activities
-12
6
Financing Activities
17
-4

Share Holding

% Holding
Sept 2024
Jan 2025
May 2025
Jun 2025
Sept 2025
Promoter
100.00 %
100.00 %
73.50 %
73.50 %
73.52 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
19.44 %
21.46 %
22.85 %
Others
0.00 %
0.00 %
7.06 %
5.04 %
3.63 %
No of Share Holders
8
8
8
1,628
1,498

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
11 Jun 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Jun 2025 66.05 69.80
14 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2025 56.75 66.15

Technical Indicators

RSI(14)
Neutral
52.65
ATR(14)
Less Volatile
4.60
STOCH(9,6)
Neutral
24.48
STOCH RSI(14)
Oversold
8.30
MACD(12,26)
Bearish
-1.53
ADX(14)
Strong Trend
37.65
UO(9)
Bearish
43.39
ROC(12)
Downtrend And Accelerating
-4.97
WillR(14)
Oversold
-86.15